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Ten male rhesus monkeys, each weighing 3.5 kg, were divided into four groups of 3, 3, 2, and 2, and
were fed daily with 100 g pelleted food containing 300, 30, 3, and 0 ppm cadmium, respectively. Urine
samples were collected every 2 weeks and blood samples every 4 weeks. One monkey each ofthe 300 and
30 ppm groups was autopsied for pathological examination and tissue cadmium determination at the week
24 of the experiment; the remaining 8 animals were killed after 55 weeks.
The lowest exposed group (3 ppm) did not show any specific biological response to cadmium over a
period of 55 weeks. In the 30 ppm group, no significant changes were observed for up to 24 weeks,
although cadmium concentration in the renal cortex and urine at 24 weeks were 300/.g/g wet weight and
18,g/l., respectively. Plasma urea nitrogen and urine protein (quantitative determination) increased
after 30 and 36 weeks. At 55 weeks of the experiment, qualitative tests were negative for low molecular
weight proteinuria and glycosuria, and the results remained normal for renal and liver function tests and
blood analysis, although cadmium concentrations in the renal cortex of two monkeys were 460 and 730
,ug/g wet weight and those in the liver were 110 and 160 ,ug/g wet weight, respectively.
In the highest exposure group (300 ppm), urine cadmium increased to 250,ug/l. by 11 weeks, and urine
retinol-binding protein, plasma GOT, GPT, and LDH increased after 12 weeks. Proteinuria (quantitative
determination), glycosuria, aminoaciduria (panaminoaciduria), and erythrocytopenia were observed
after 16 weeks, when urine cadmium was 500-900, 1g/l. Hypohemoglobinopathy and proteinuria (qualita-
tive determination) were observed after 20 and 24 weeks, while cadmium concentrations in the renal
cortex and the liver were 760 and 430 ,lg/g wet weight at 24 weeks, respectively. Slightly depressed
tubular reabsorption of phosphate, increased urine 832-microglobulin, increased plasma urea nitrogen,
and increased plasma a2-globulin fraction (electrophoresis) were observed between 28 and 30 weeks ofthe
experiment. Creatinine clearance and plasma cholinesterase decreased after 47 and 54 weeks, respec-
tively. Cadmium concentrations in the renal cortex and the liver oftwo monkeys at 55 weeks were 350 and
580 ,ug/g wet weight and 410 and 630 ,g/g wet weight, respectively. Pathological examinations revealed
denaturation, destruction, and regeneration of the epithelial cells in renal proximal tubules, but no
pathological changes in osseous tissues.
Critical cadmium concentration in the renal cortex was estimated to be 380 ,uLg/g wet weight for low
molecular weight proteinuria and 470 ,ug/g wet weight for proteinuria, glycosuria, and aminoaciduria.
Critical concentration in the liver was also estimated to be 210 ,tg/g wet weight. The apparent biological
half-time ofcadmium in monkeys at autopsied stage was calculated to be 0.66, 6.4, 5.2, and 22.4 years for
the 300, 30, 3, and 0 ppm groups, respectively.
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223 February 1979cadmium on inhabitants of cadmium-polluted areas
in Japan. While health surveys have been per-
formed in cadmium-polluted areas, animal experi-
ments have been conducted to elucidate the
mechanism and early detection of cadmium
poisoning (3). However, most animal experiments
have been carried out on mice and rats, and occa-
sionally on rabbits. Therefore, experimental results
are not always applicable directly to cadmium
health effects on human. Besides, animals in those
experiments have been exposed to cadmium at far
higher dose levels than actual exposure levels in
human. This is why it was very important to expose
monkeys to cadmium at relatively low levels for a
prolonged period. This experiment was primarily
focused on the dose-response relationship of cad-
mium. As many clinical pathology determinations
were performed as possible to find criteria for
evaluating cadmium toxicity. Critical concentration
and biological half time of cadmium in monkeys
were also determined.
Materials and Methods
Ten male rhesus monkeys, Macaca mulatta, im-
ported from India, were purchased after quarantine
through the Shizuoka Prefecture Agricultural Cor-
poration for Experimental Animals. They weighed
3.5 kg and were estimated to be 2.0-2.5 years old.
After maintaining them for 10 weeks in steel cages
with Oriental monkey pelleted food, they were di-
vided into four groups at random after gradation by
body weight; three monkeys ofthe first group were
given 30 mg cadmium per day as cadmium chloride
by oral route, three monkeys ofthe second group 3
mg cadmium/day, two monkeys of the third group
0.3 mg cadmium/day, and two monkeys of the last
group 0 mg cadmium/day, respectively. Originally,
in September 1976, cadmium was given to monkeys
mixed into a 0.5 g biscuit; animals on high doses
refused for several days to consume these biscuits.
Subsequently, orange-flavored biscuits were given
to these monkeys instead ofordinary cadmium bis-
cuits, but these also were refused. Even starvation
failed to cause the animals to eat the biscuits. Fi-
nally, the monkeys were given CLEA (Central
Laboratory for Experimental Animals, Tokyo)
monkey pelleted food containing 300, 30, 3, and 0
mg cadmium/kg with orange flavor; this food was
readily accepted. The monkeys were given 100 g
pelleted food containing cadmium at four levels and
half an apple daily throughout the experimental
period. The levels 30, 3, 0.3, and 0 mg cadmium/
head/day group are termed the 300, 30, 3 and 0 ppm
groups in the present paper. In addition 30 g ordi-
nary pelleted food containing 0.13 mg cadmium/kg
was provided per day starting in May of 1977.
At 2-week intervals, samples of urine and feces
were collected for clinical pathology and cadmium
assay. Immediately after collection, urine samples
were divided into two parts: to one portion was
added sodium azide to afinal concentration of0.1%
prior to storage at 4°C. Urine cadmium was deter-
mined by direct Zeeman effect atomic absorption
spectrophotometry (4). Urine samples were diluted
with distilled water to a final concentration of ap-
proximately 20 ng/ml and acidified with nitric acid
(final concentration 0.IN). The Hitachi Zeeman ef-
fect atomic absorption spectrophotometer, Type
170-70, equipped with Perkin-Elmer auto sampling
system AS-I was used for cadmium determination.
Urine protein and amino acid were determined by
the Tsuchiya-Biuret method (5) and the TNBS
method (6). Acidity, protein (qualitative determina-
tion), and glucose were evaluated by tape. Plasma
and urine creatinine were determined by the method
ofFolin-Wu (7), plasmaand urine phosphate by that
of Fiske-Subbarow (8), plasma calcium by atomic
absorption spectrophotometry, plasma protein by
refractometry, plasma GOT and GPT by the stan-
dard procedures of Japan Association of Digestive
Systems (Reitman-Frankel unit) (11), plasma LDH
by the method of Wroblewski (12), plasma leucine
amino peptidase (LAP) by the method of Goldbarg
and Rutenburg (13), plasma alkaline phosphatase
(ALP) by the method ofKind and King (14). Isoen-
zymes of alkaline phosphatase and leucine
aminopeptidase were also studied. Erythrocyte and
leucocyte counts were determined by automatic
blood cell counter (Coulter Counter) and hemoglo-
bin by the cyanmethemoglobin method (IS). Elec-
trocardiograms and blood pressure were recorded
under ketamine hydrochloride anesthesia after
Hirayama's procedure (16) for A-B and ordinary
limb leads. Blood pressure was also measured at 55
weeks by both indirect and direct methods. The
latter measurement was performed with the use ofa
carotid artery catheter.
At the 24th week ofthe experiment, one monkey
from each ofthe high exposure groups was killed for
pathological examination and tissue cadmium de-
termination; the remaining eight monkeys were
killed after 55 weeks. For tissue cadmium determi-
nation, tissues were weighed at the level of 10-3 g
accuracy and then kept at -20°C. At the time of
cadmium determination, samples were thawed and
wet-ashed with nitric acid and perchloric acid. Tis-
sue cadmium was determined by a Varian-
Techtoron atomic absorption spectrophotometer,
Type AA-l 100 equipped with background corrector
BC-6 (D2 lamp).
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Body Weight
Monkeys of the 0 ppm group gained weight at a
rate of21 g/week over a period of55 weeks (Fig. 1).
Some monkeys in the 3 and 30 ppm groups showed
little gain in body weight. Monkeys in the 300 ppm
group showed almost no gain in body weight over a
period of 55 weeks.
Feces Weight
Monkeys ofthe 0, 3, and 30 ppm groups excreted
20-40 g/day feces in the early experimental period,
but feces weight increased to 100 g/day at the end of
the experiment. Feces weight ofthe 300 ppm group
varied widely between individuals, but did not in-
crease during the experiment.
Urine
Volume. Urine volume of the four groups
showed no changes throughout the experiment.
pH. Urine pH was not changed by cadmium
administration.
Urine Protein (Qualitative). The qualitative
test for proteinuria was negative in the 0, 3, and 30
ppm groups throughout the experiment. One mon-
key of the 300 ppm group showed some initial pro-
teinuria after 24 weeks, which became very marked
after 50 weeks; another monkey showed proteinuria
after 36 weeks.
Urine Protein (Quantitative). No increase
was observed in urine protein of the 0 and 3 ppm
groups over a period of55 weeks (Fig. 2). The aver-
age urine protein concentration was 9.0 mg/dl. One
monkey of the 30 ppm group showed a slight in-
crease after the 36th week. Two of three monkeys
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FIGURE 1. Body weights: 0 ppm group, (-) monkey #1248, (X)
monkey #1259; 3 ppm group, (-) monkey #1244, (X) mon-
key #1249; 30 ppm group, (@) monkey #1202, (X) monkey
#1247, (0) monkey #1258; 300 ppm group, (0) monkey
#1213, (X) monkey #1243, (0) #1253.
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FIGuRE 2. Urine protein (quantitative). Symbols as in Figure 1.
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February 1979ofthe 300 ppm group indicated an increase in urine
protein concentration after 15th week. These mon-
keys also exhibited glycosuria I week later. The
urine protein concentration of the third monkey of
the 300 ppm group increased after the 36th week;
glycosuria was also present. Two ofthree monkeys
ofthe 300 ppm group showed first a sharp transient
increase after 15 weeks, followed large increases
after 20 weeks.
Urine Glucose (Qualitative). Qualitative tests
for glycosuria in the 0 and 3 ppm group monkeys
were generally negative and only occasionally
slightly positive (Fig. 3). The monkeys in the 30
ppm group were negative to the qualitative test for
glycosuria over a period of 55 weeks. Two of three
monkeys of the 300 ppm group monkeys showed
glycosuria after 16 weeks of the experiment.
Glycosuria was generally detected intermittently in
the first stage and persistently in the later stage.
Urine Amino Acids. The urine amino acid con-
centration of the 0, 3, and 30 ppm groups remained
at a normal level 5.8 ± 1.6 mM (average and one
standard deviation of 10 untreated monkeys) over a
period of 55 weeks (Fig. 4). Two of three monkeys
of the 300 ppm group showed an increase in urine
amino acid concentration (12-20 mM) after 15 or 16
weeks. The last monkey of the 300 ppm group
showed a gradual increase in urine amino acid con-
centration after 44 weeks. However, it should be
noticed here that the amino acid concentration of
the 300 ppm group was not statistically different
from that of the 0 ppm group.
Amino Acid Analysis of Urine. One monkey
each ofthe 30 and 300 ppm groups at 24 weeks and 8
other monkeys ofthe 0, 3, 30 and 300 ppm group at
55 weeks were subjected to amino acid analysis of
urine. In the 300 ppm group, proline was the amino
acid present in highest concentration; this was fol-
lowed by hydroxyproline, threonine, serine,as-
paragine, citruline, alanine, lysine, and histidine (Table
1). These data suggest that the monkeys suffered from
panaminoaciduria.
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FIGURE 3. Urine glucose (qualitative). Symbols as in Figure 1.
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FIGURE 4. Urine amino acid. Symbols as in Figure 1.
Environmental Health Perspectives 226Urine f32-Microglobulin-like Protein. The mon-
keys excreted two kinds of f32-microglobulin-like
protein of different molecular weights but with
electric mobilities almost the same as that ofhuman
f82-microglobulin (16) (Fig. 5). Furthermore, human
and monkey f82-microglobulins possess common
antigens (16), and monkey urine /82-microglobulin-
like protein could be determined by a micro-
Ouchterlony method with the use ofhuman antisera
at a detection limit of 0.71 mg/dl human /32-
microglobulin.
In monkeys of the 30 ppm group, urine 132-
microglobulin-like protein was not detectable overa
period of55 weeks. One oftwo monkeys ofthe 300
ppm group indicated a positive immunological test
to,/2-microglobulin-like protein after the 30th week.
The protein concentration increased gradually to
5.68 mg/dl at 52 weeks of experiment, although it
fluctuated from day to day.
Urinary Protein Similar to Retinol-Binding
Protein. As reported by Nomiyama and
Yotoriyama (16), monkeys excrete protein of the
same molecular weight, electric mobility, and an-
tigeneity as human retinol-binding protein (RBP).
Urine RBP-like protein could be determined with
the use of human antisera by a micro-Ouchterlony
method and cross immunoelectrophoresis at detec-
tion limits of0.31 and 0.04 mg/dl, respectively.
In the 30 ppm group, RBP-like protein was not
detectable in urine over a period of 55 weeks (Fig.
6). In the 300 ppm group, the qualitative test by the
cross immunoelectrophoresis for RBP-like protein
became positive in one of two monkeys after 12
weeks. After 24 weeks it became positive by the
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micro-Ouchterlony method. Urine RBP-like protein
concentration increased gradually with time of ex-
posure. In another monkey receiving 300 ppm,
RBP-like protein became positive after 54 weeks.
Plasama Urea Nitrogen
Plasma urea nitrogen of untreated monkeys was
23.1 + 4.6 mg/dl (average + standard deviation). No
specific changes were observed in the 0 and 3 ppm
groups. The 30 and 300 ppm groups showed rela-
tively high plasma urea nitrogen concentration after
the 36th week.
Creatinine Clearance (Ccr)
Average creatinine clearances of the 0, 3, and 30
ppm groups were 12.2 + 2.2 m/min (Fig. 7), and no
effects of Cd were observed during 55 weeks ex-
periment. On the other hand, the creatinine clearance
of the 300 ppm group decreased to 8 ml/min (63% of
normal level) after the 47th week.
Tubular Reabsorption ofPhosphate (%TRP)
Average tubular reabsorption of phosphate was
99.6% in the 0, 3, and 30 ppm groups (Fig. 8). No
decrease was observed over a period of 55 weeks.
One oftwo monkeys ofthe 300 ppm group showed a
decrease in tubular reabsorption ofphosphate after
28 weeks. Another monkey of the 300 ppm group
showed a slight decrease in tubular reabsorption of
phosphate after the 36th week. Tubular phosphate
reabsorption in these monkeys fluctuated from day
to day, but gradually fell to values of96.7 and 96.1%
after 55 weeks.
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FIGURE 5. Urine,82-microglobulin-like protein: (O, X) 300 ppm;
(0, A) 30 ppm.
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FIGURE 6. Urine retinol-binding protein. Symbols as in Figure 5.
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Blood Glucose. The blood glucose ofuntreated
monkeys was 87 ± 13 mg/dl. None of the 0, 3, 30,
and 300 ppm group monkeys showed any changes in
blood glucose.
Erythrocyte Count. Erythrocyte counts of the
0, 3, and 30 ppm group monkeys remained at 580 +
22 x 104 /mm3 throughout all 55 weeks. The eryth-
rocyte count ofthe 300 ppm group monkeys after 16
weeks decreased gradually with cadmium adminis-
tration to 290 x 104/mm3 (48% of normal count) at
the 55th week.
Leucocyte Count. There were no changes of
leucocyte count which could be attributed to cad-
mium administration. The leucocyte count of un-
treated monkeys was 15,400 ± 3,400/mm3, but
showed large individual differences.
Hemoglobin Content. The hemoglobin level in
blood of untreated monkeys was 13.7 ± 0.8 g/dl.
(Fig. 9). Hemoglobin contents of the 3 and 30 ppm
groups did not change following cadmium adminis-
tration. The hemoglobin content for the 300 ppm
group monkeys after 20 weeks began to decrease to
7.3 + 0.7 g/dl (53.2% of untreated monkeys) at the
55th week.
Hematocrit (Ht). The hematocrit of untreated
monkeys was 41.3 ± 2.1%. The 3 and 30 ppm group
monkeys did not show any effects of cadmium on
hematocrit. The hematocritofthe 300ppmgroup mon-
keysdecreased to20.0 ± 1.4% (48.4% ofnormallevel)
at the 55th week.
Hemogram. Eosinophils constituted 3.0 +
2.2% ofleucocytes of untreated monkeys. None of
the 3, 30, and 300 ppm group monkeys showed con-
sistent alterations due to cadmium administration.
Stab-form leucocytes of untreated monkeys con-
stituted 0.7 ± 0.8% of total leucocytes. No cad-
mium effects were observed in any monkeys.
Segmented leucocytes in untreated monkeys with
two lobules constituted 14.8 ± 10.6% oftotal leuco-
cytes, those with three lobules 10.5 + 7.4%, four
lobules 1.4 ± 1.1% and over five lobules 0%o. No
cadmium effect was observed in the 3 and 30 ppm
group monkeys. Stab-form leucocytes and seg-
mented leucocytes with two and three lobules in the
Table 1. Amino acid analysis of urine of monkeys given oral cadmium administration.
Amino acid level, mM
0 ppm group 3 ppm group 30 ppm group 300 ppm group
Amino Acids #1248 #1259 #1244 #1249 #1202a #1247 #1258 #1253a #1213 #1243
Phosphoserine 0.11
Taurine 4.43 2.98 1.10 2.83 0.78 0.80 0.98
Hydroxyproline 0.35 1.70
Aspartic acid 0.08 0.08 0.20 0.08 0.25 0.85
Threonine 0.07 0.30 0.04 0.90 4.63
Serine 0.25 0.03 0.82 0.35 3.88
Asparagine 0.20 0.10 1.66 1.03 4.70
Proline 1.44 1.20 11.1
Glutamic acid 0.25 0.30 0.40 0.20 0.93 1.13
Citrulline 0.63 0.53 1.0 0.28 1.50 0.88 2.78
Glycine 5.95 5.0 1.37 1.55
Alanine 0.03 0.77 0.68 2.23
Valine 0.25 0.83
Cystine 0.26 0.15 0.53
Cystathionine 0.03 0.06 0.05
Methionine 0.07
Isoleucine 0.10 0.08
Leucine 0.12 0.28
Tyrosine 0.41 1.33
Phenylalanine 0.04 0.29
y-Amino-n-butyric acid 0.85 0.38 2.2 0.98 0.18 0.78 0.35 0.10 0.18 0.63
Ornithine 0.05 0.20 0.54 0.48 1.70
Ethanolamine 0.45 0.22 0.44
Ammonia 1.35 0.83 1.73 0.83 0.49 1.75 0.75 2.5 6.75
Lysine 0.18 0.58 1.33 0.07 0.28 1.75 2.48
1-Methylhistidine 0.97 0.05
Histidine 0.02 0.89 1.03 4.43
3-Methylhistidine 0.08 0.08
Arginine 0.03 0.35
Total amino acids 2.50 11.67 5.13 10.77 4.14 3.51 5.09 9.67 10.9 45.5
(except for ammonia)
a Sacrificed at 24 weeks of the experiment.
Environmental Health Perspectives 228300 ppm group monkeys showed relatively higher
ratios: stab-form leucocytes 2.0 ± 1.2%, two
lobule-segmented leucocytes 14.7 ± 4.8% and three
lobule-segmented leucocytes 15.8 ± 2.7%. A ten-
dency for a shift of the hemogram to the left was
observed.
Monocytes of untreated monkeys constituted 0.1
± 0.3% oftotal leucocytes. The 3, 30, and 300 ppm
group monkeys did not show any cadmium effects.
The lymphocyte count ofuntreated monkeys was
69.0 ± 16.5% of total leucocytes. Lymphocytes of
the 300 ppm group was found a little smaller than
those of other groups.
No atypical leucocytes were observed in control
monkeys. On the other hand, atypical leucocytes
were intermittently observed in the 30 and 300 ppm
group monkeys.
Plasma Protein, Plasma Enzymes, and
Plasma Electrolytes
Plasma Protein Concentration The plasma
protein concentration ofcontrol monkeys was 8.3 ±
0.3 g/dl. No cadmium effects were observed.
Electrophoresis of Plasma Protein. The
plasma albumin/globulin ratio (A/G) in untreated
monkeys was 1.71 ± 0.30. In the 300 ppm group the
A/G ratio was somewhat lower over a period of 55
weeks, but no change was observed during the ex-
periment (1.58 ± 0.31).
The plasma albumin fraction of control monkeys
was 62.7 ± 4.6%. The plasma albumin of the 300
ppm group monkeys was slightly low although they
were not significantly different from that ofcontrol
monkeys.
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FIGURE 7. Creatinine clearance. Symbols as in Figure 1.
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229The plasmaa,-globulin ofuntreated monkeys was
4.7 + 1.4% of total protein. No significant change
was observed in cadmium treated monkeys.
The plasma a2-globulin fraction of control mon-
keys was 5.5 + 1.1% of total protein. No change
was observed due to cadmium.
The plasma ,-globulin of control monkeys was
12.7 ± 3.2%. No cadmium effect was observed.
The -y-globulin fraction ofplasma ofcontrol mon-
keys was 13.9 ± 2.4%. No cadmium effects were
observed during the experiment.
Plasma GOT. Plasma GOT of the 0 ppm group
was 34 ± 3 units (Fig. 10). In the 0, 3, and 30 ppm
group monkeys no change with time was observed.
GOT of all three monkeys of the 300 ppm group
increased to 60 + 13 units after 12 weeks.
Plasma GPT. Plasma GPT of untreated mon-
keys was 31 ± 3 units (Fig. 11). The GPT ofthe 0, 3,
and 30 ppm group monkeys showed no cadmium
effect, while the GPT of the 300 ppm group mon-
keys increased to 66 ± 10 units after 12 weeks.
Plasma LDH. The plasma LDH of untreated
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FIGURE 9. Hemoglobin content. Symbols as in Figure 1.
monkeys was 521 + 30 units (Fig. 12). The 0, 3, and
30 ppm group monkeys did not show any change in
plasma LDH due to cadmium administration.
Plasma LDH of the 300 ppm group monkeys in-
creased significantly to 848 ± 112 units after 12
weeks.
Plasma Alkaline Phosphatase. Alkaline phos-
phatase of untreated monkeys was 51 ± 9 units.
None of the three groups of monkeys (0, 3, and 30
ppm groups) showed changes due to cadmium ad-
ministration. One of two animals in the 300 ppm
group showed an elevated alkaline phosphatase
level.
Plasma Alkaline Phosphatase Isoenzyme. In
monkey plasma, a single band of alkaline phos-
phatase was detected just corresponding to human
alkaline phosphatase3 (ALP3) on electrophoresis.
This monkey alkaline phosphatase was different
from osseous alkaline phosphatase in heat tolerance
test. The alkaline phosphatase isoenzyme pattern was
not changed by cadmium over a period of 55 weeks.
Plasma Cholinesterase. The cholinesterase
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Environmental Health Perspectives 230level of untreated monkeys was 0.96 + 0.14 units.
Cadmium did not change cholinesterase in the 0, 3,
and 30 ppm group monkeys, but 300 ppm cadmium
depressed cholinesterase to 0.70 units (72.9% of
normal level) at 54-55th week. The significance of
this is uncertain.
Plasma Leucine Aminopeptidase (LAP).
Leucine aminopeptidase of untreated monkeys was
54.1 ± 7.4 units. Leucine aminopeptidase of all
monkeys in the 0, 3, 30, and 300 ppm groups de-
creased throughout the experiment. The average
activity was 19.5 ± 2.2 units (36.0% ofnormal level)
at 51 weeks. No dose-response relationships were
observed between cadmium level and decreases in
leucine aminopeptidase.
Plasma Leucine Aminopeptidase Isoen-
zyme. There was a single peak or several peaks of
plasma leucine aminopeptidase isoenzymes corre-
sponding to human a1-globulin on electrophoresis.
However, dose-response relationships were not ob-
served in the pattern over a period of 55 weeks of
experiment.
Plasma Monoamine Oxidase (MAO). Plasma
monoamine oxidase was measured at the 55th week
(Table 2). Monoamine oxidase levels ofthe 0, 3, and
30 ppm group monkeys were 369 + 16 units, while
those of the 300 ppm group monkeys were 31 and
272 units.
Plasma Sodium. The plasma sodium of un-
treated monkeys was 144 + 3 meq/l. Cadmium had
no effect on plasma sodium.
Plasma Potassium. The plasma potassium of
untreated monkeys was 4.6 + 0.7 meq/l. All animals
showed a tendency to decrease this level to 3.0 +
0.1 meq/l (65% of normal level) at 55th week. No
dose-response relationships between cadmium dose
level and plasma potassium were observed.
Plasma Chlorine. Plasma chlorine was deter-
mined at intervals, and no significant change was
observed following cadmium administration.
Plasma Calcium. Plasma calcium was also de-
termined at intervals. Plasma calcium of control
monkeys was 10.3 + 0.2 meq/l. No dose-response
relationships between cadmium dose level and
'I~~~~~~~~~~V
-
I:
If/ \
-)--_ ,X ')
0 10 20 30 40 50 60
WEEKS
FIGURE 11. Plasma GPF. Symbols as in Figure 1.
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231plasma calcium were observed.
Plasma Phosphate. Plasma phosphate of un-
treated monkeys was 6.60 + 0.88 meq/l. (Fig. 13).
The 0 ppm group monkeys showed no change in
plasma phosphate during the experiment, and al-
most no change was also observed in the 30 ppm
group monkeys. Plasma phosphate decreased
markedly to 1.63 meq/l. (26.8% ofnormal level) in the
300 ppm group monkeys at 55th week.
Electrocardiogram and Blood Pressure
As indicated above, electrocardiograms were
recorded twice after 44 and 52 weeks of the experi-
ment. No effects of cadmium were recognized on
these two electrocardiograms (Fig. 14). Two mon-
keys of the 300 ppm group showed relatively low
voltage in QRS; this however was also frequently
observed in normal monkeys. Maximum blood
pressures of all animals were between 110 and 140
mm Hg. No cadmium effect, such as elevation in
blood pressure, was observed. Blood pressure was
measured by the direct method at the time of au-
topsy, and two monkeys ofthe 0 ppm group showed
a higher blood pressure (152 and 176 mm Hg) than
did the cadmium exposed animals.
Urine Cadmium
Urine cadmium concentration and urinary excre-
tion of cadmium of eight untreated monkeys were
1.33 ± 1.09,tg/l. (average + one standard devia-
tion); and 0.29 + 0.16 ,g/day; of nine animals one
showed values of 13.3,g/l. and 1.26,ug/day and was
omitted.
The urine cadmium concentration of the 3 ppm
group monkeys fell into the range of 1-10,ug/l. (Fig.
15). The urine cadmium concentration ofthe 30 and
300 ppm group monkeys increased right after cad-
mium administration was begun. The urine cad-
mium level of two of three monkeys of the 30 ppm
group was between 20 and 60 ,g/l. at 4-8 weeks,
and the last monkey of the 30 ppm group reached
the same level at 28 weeks. Two ofthree monkeys
ofthe 300 ppm group reached the maximum level at
the 16th week and remained almost at the same
concentration afterwards; the cadmium concentra-
tion of monkey #1213 was between 200 and 300
,ug/l. and that of monkey #1243 was between 700
and 1000 ,ug/l. The urine cadmium concentration of
monkey #1243 ofthe 300 ppm group was as high as
2000,ug/l. in the 55th week ofexperiment. In one of
two monkeys of the 0 ppm group (monkey #1248),
urine cadmium concentration was high before the
experiment. Though it decreased with the beginning
of the experiment, it was still significantly higher
than that of untreated monkeys.
Excessive cadmium was excreted in the 0 ppm
group. Urinary excretion of cadmium of the 3 ppm
group increased to 1-5 ,ug/day until 11 weeks. The
urinary excretion of cadmium of the 30 ppm group
increased to 5-15 ,g/day up to week 22-28 and re-
mained at that level afterwards. Urinary excretion
Table 2. Effects of dietary cadmium on serum MAO.
Cadmium Animal Serum MAO
level, ppm 54 Weeks 55 Weeks
300 1213 56 31
1243 28 272
30 1247 220 378
1258 846 338
3 1244 663 381
1249 408 365
0 1248 64 377
1259 907 374
Untreated 1201 433
1254 524
MEQ/L
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FIGURE 13. Plasma phosphate. Symbols as in Figure 1.
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of cadmium of the 300 ppm group increased till the
16-18th week and remained between 100 and 350
jig/day. One monkey ofthe 300 ppm group excreted
680 ,ug/day (2.3% of dietary cadmium 30 mg/day)
into urine at 55th week of experiment.
Fecal Cadmium
The cadmium concentration in feces ofuntreated
monkeys was 70 + 37,g/g, except 210,g/g in mon-
key #1213. Fecal cadmium increased right after the
cadmium administration and remained at the same
level, depending on the feeding level throughout the
experimental period; 10-80, 30-100, and 600-1000
,ug/g for the 3, 30, and 300 ppm groups, respec-
tively. Only monkey #1248ofthe0 ppm group showed
alarge variation offeces cadmium rangingfrom 1 to 70
Lg/g.
Organ Weight
On autopsy the following organs were weighed;
spleen, pancreas, liver, kidney (right and left, and
cortex and medulla, separately), testis (right and
left), adrenal glands (right and left), thymus (right
and left), submandibular glands (right and left),
lung, heart, thyroid (right and left), parotid (right
and left), brain. Results are shown in Table 3. No
specific changes due to cadmium were observed.
Tissue Cadmium
Tissue cadmium concentrations are listed in
Table 4. A higher tissue cadmium concentration
was detected in monkeys at the higher doses. The
liver to renal cortex ratio was higher in the higher
cadmium dose groups. Independently ofdose level,
the highest tissue cadmium concentration was ob-
served in the renal cortex and the liver. Other tis-
sues with high cadmium concentrations were renal
medulla, pancreas, adrenal glands, spleen, subman-
dibular gland, and parotids. Cadmium concentra-
tion was low in cerebrum, cerebellum, and skull,
but higher in ribs.
As for cadmium content in the organs (Table 5),
the largest cadmium reservoir was the liver, and the
higher cadmium accumulation rate was observed in
the liver especially for a higher cadmium dose level
group. The other organs with large cadmium con-
tent were kidneys, pancreas, submandibular glands,
parotids and heart.
Pathological Findings
All monkeys were necropsied after drawing
whole blood under Ketamine hydrochloride anes-
thesia.
The detailed information is contained in Table 6,
and only the main topics will be described here.
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FIGURE 15. Urine cadmium.
There were vacuolar degeneration and small ne-
crotic foci in the peripheral zone ofhepatic lobules
of the 300 ppm group monkeys (Fig. 16).
Slight swelling and faint disintegration of brush
borders of renal tubular epithelium were observed
in the 3 and 30 ppm group.
In the 300 ppm group monkeys, there were the
area ofdegeneration to necrosis and regeneration of
epithelium of renal proximal tubules with distinct
mitotic figures.
No pathological changes were observed in osse-
ous tissues.
No significant lesion in other organs was proved,
regardless of any dose level of cadmium.
Discussion
Biological Responses to Cadmium
In the present experiment, monkeys which were
given pelleted food containing 300 ppm cadmium
were found to suffer from anemia and renal and
hepatic dysfunction after 12 weeks. There have
been very few other reports, however, on clinical
picture of animals given cadmium for more than
year (18, 19). Nomiyama et al. (18) reported that
rabbits fed 300 ppm cadmium over a period of 54
weeks showed aminoaciduria after 16 weeks and
proteinuria and glycosuria after 40 weeks.
Nomiyama and Nomiyama (19) also reported on
Environmental Health Perspectives 234Table 3. Tissue weight of rhesus monkeys.
Tissue weights, g
300 ppm 30 ppm 3 ppm Oppm
#1253a #1213b #1243b #1202a #1247b #1258b #1244b #1249b #1248b #1259'
Body weight 3650 4630 4010 4080 4360 6130 5170 4970 4830 5280
Spleen 5.3 3.3 3.4 4.6 4.6 4.8 4.8 5.2 6.7 3.6
Pancreas 9.2 12.0 9.3 11.4 13.7 14.6 9.6 13.7 13.5
Liver 78.5 104.0 96.5 91.3 106.9 133.4 97.5 97.9 102 103
Kidneys
Right 16.7
Left 15.1
Testis
Right 2.2
Left 1.7
Adrenals
Right 0.28
Left 0.35
Thymus 3.3
Brain 89.6
Renal cortex
Renal medulla
Lungs 38.6
Heart 17.9
Thyroids
Right 0.42
Left 0.37
Mandibular glands
Right 1.67
Left 1.70
Parotids
Right
Left
a After 24 weeks.
b After 55 weeks.
11.7 14.5
11.0 16.2
9.2 9.2 11.5 14.5
8.9 9.2 10.1 14.7
1.6
1.6
- 15.2
14.8
9.2 11.0
9.4 10.5
9.6 12.4
10.4 11.5
4.4 10.6 22.6 13.7
3.5 11.2 21.2 12.6
0.44 0.3 0.29 0.29 0.30 0.32
0.47 0.3 0.26 0.50 0.40 0.31
3.1 1.2 3.8 10.0 7.3 9.0 5.1
95.0 78.5 90.5 96.9 106.1 91.0 87.7
7.94 8.34 7.67 9.30
0.91 0.85 0.74 0.83
28.8 -
16.4 17.5 15.6 38.5 17.8 22.4
0.30 0.45 0.42
0.26 0.63 0.7
1.88 1.34
2.52 1.31
8.4 11.7
5.8 10.6
0.4 0.37 0.49
0.53 0.48 0.49
6.5 3.4
6.3 5.5
1.9 12.3
1.7 11.4
1.7
1.9
4.1
4.3
0.3 0.42
0.53 0.53
- 13.8
97.5 92.0
8.82
- 0.93
21.7 18.7
0.16 0.18
0.29 0.28
- 3.08
- 4.08
9.1
7.2
Table 4. Tissue cadmium of rhesus monkeys fed CdCI2.
Tissue concentration of Cd, ,g/g wet weight
300 ppm 30 ppm 3 ppm Oppm
Tissue #1253a #1213b #1243b #1202a #1247b #1258b #1244b #1249b #1248b #1259b
Spleen 33.6 50.4 26.7 10.9 9.5 2.2 2.8 2.5 1.2
Pancreas 150.0 79.6 23.7 5.6 6.5 3.7 2.1
Liver 426.5 630.4 409.8 55.8 161.4 111.9 40.8 36.0 36.2 16.8
Renal cortex 756.5 582.7 350.2 299.5 727.3 464.8 160.7 243.0 180.2 145.1
Renal medulla - 154.9 128.2 69.1 72.8 21.6 29.6 25.2
Testis 18.9 7.7 2.6 6.0 1.7 0.7 0.6 0.3 0.2
Adrenal 72.1 125.9 62.7 14.2 31.6 24.7 5.2 5.2 4.0 1.7
Thymus 20.3 28.3 29.8 1.1 2.2 1.9 0.5 0.9 0.6 0.2
Lung 17.8 11.7 1.2 3.6 0.1 1.3 0.7 0.6 0.4
Heart 24.2 43.6 23.4 2.3 5.2 3.9 0.4 0.6 0.4 0.3
Thyroid 13.4 18.6 0.0 3.9 3.3 1.9 2.4 1.0 0.3
44.3
9.1
40.5
41.5
0.00
52.0 43.2 6.2
45.4 21.1
20.32 10.93 0.9
4.3 3.9 -
1.5 1.1 0.0
1.9 1.2 0.0
- 30.6
5.8
81.1 16.7
5.20 4.03 0.35
1.32 3.80 0.00
13.4
6.6
2.3
2.0
0.4
0.5
8.5
8.8
1.02
0.56
8.9
5.1
1.68
0.7
0.3
0.3
12.5
1.5
1.9
0.56
1.9
2.1
0.48
1.8
0.1
0.1
6.6
1.6
1.7
0.37
0.03
2.5
1.5
0.76
1.7
0.2
0.1
5.2
1.3
0.7
0.28
0.05
1.8 1.0
1.7 1.1
0.34 0.25
0.2 0.1
0.1 0.1
0.1 0.0
2.5 1.1
1.3 0.4
1.1 0.5
0.11 0.09
0.03 0.00
a After 24 weeks.
b After 55 weeks.
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11.4
11.5
0.32
0.27
2.5
2.5
Mandibular
gland
Parotids
Rib
Skull
Cerebrum
Cerebellum
Intestine
Serosa
Mucosa
Cecum
Colon
Muscle
BileTable 5. Cadmium concentration in rhesus monkey organs.
300 ppm 30 ppm 3 ppm 0 ppm
#1253 #1283 #1243 #1202 #1247 #1258 #1244 #1249 #1248 #1259
Body weight, kg 3.65 4.63 4.01 4.08 4.36 6.13 5.17 4.97 4.83 5.28
Cadmium content in organs, ug
Spleen 178.1 166.3 90.8 50.1 45.6 10.6 14.6 16.8 4.6
Pancreas 1800 740 325 82 62 51 28
Liver 33,480 65,562 39,546 5,095 17,254 14,928 3,978 3,524 3,692 1,730
Kidney
Total 6,126 1,847 - 4,834 3,195
Cortex 5,920 1,7 2,726 4,796 - 3,137
Medulla - - 306.2 138.1 38.1 57.4
Testis (R&L) 429.0 236.4 8.3 51.0 5.5 13.1 13.1 5.3
Adrenals (R&L) 45.4 114.6 37.6 7.8 19.5 3.6 3.3 3.3 1.6
Thymus 67.0 87.7 35.8 4.2 22.0 13.9 4.5 4.8 2.8
Lung 34.6
Heart 433.2 715.0 409.5 35.9 200.2 7.1 13.4 8.7 5.6
Mandibular glands 149.3 260.0 190.1 16.40 171.5 79.2 - 9.0 7.2
Parotid glands 644.7 468.8 23.8 120.9 12.6 17.9
Parotid glands 7.91 10.42 0.00 4.37 3.07 1.62 2.35 0.45 0.14
Parotid glands 644.7 468.8 23.8 120.9 12.6 17.9
Thyroid 7.91 10.42 0.00 4.37 3.07 1.62 2.35 0.45 0.14
another group ofrabbits given 300 ppm ofcadmium
over a period of54 weeks. Animals stopped gaining
weight after 10 weeks, and exhibited aminoaciduria
after 21 weeks, and proteinuria after 27 weeks. In
these studies, however, liver dysfunction and low
molecular weight proteinuria were not observed.
These results are, therefore, difficult to compare with
the present experiment.
In the present experiment on cadmium health ef-
fects in monkeys, proteinuria, glycosuria, and
aminoaciduria were detected intermittently at first
and then continuously during cadmium intoxica-
tion. This result agrees well with reports on cad-
mium health effects in rabbits (18, 20); it also brings
to mind a report on itai-itai disease patients with
renal failure, who showed intermittent proteinuria
and/or glycosuria in the early stage of itai-itai dis-
ease and persistent proteinuria, glycosuria, and
aminoaciduria in the later stage (21). Therefore, in
order to detect health effects of cadmium in resi-
dents of cadmium-polluted areas at an early stage,
proteinuria, glycosuria, and aminoaciduria should
be looked for repeatedly at suitable intervals.
It was found that low molecular weight pro-
teinuria, especially retinol-binding proteinuria, is
detectable by the use of cross-immuno-
electrophoresis earlier than other symptoms of in-
toxication, such as proteinuria, glycosuria, and/or
aminoaciduria. The antiserum to human retinol-
binding protein was used in the present experiment.
The antigenicity of monkey retinol-binding protein
was almost the same as that of human beings (16),
and an effect of cadmium in monkeys was detecta-
ble with the use of human anti-retinol-binding pro-
tein sera earlier than with other tests. On the other
hand, monkeys and humans appear to have com-
mon antigens for,832-microglobulin (16), and monkey
/32-microglobulin was detectable with low sensitiv-
ity also by a micro-Ouchterlony method with the
use of human antisera (Biochemical Industry,
Tokyo). Urine ,32-microglobulin concentration of
monkey #1243 in the 300 ppm group was found to
increase after 30 weeks of experiment. Specific
antisera for monkey f2-microglobulin and cross-
immunoelectrophoresis might enhance the detec-
tion limit, and f32-microglobulin as well as retinol-
binding protein shall become sensitive indices for
early diagnosis in the future.
Slight general proteinuria, glycosuria, amino-
aciduria, and renal dysfunctions were detected later
than low molecular weight proteinuria. The 300 ppm
group monkeys showed slightly decreased tubular
reabsorption of phosphate after 28-36 weeks, in-
creased plasma urea nitrogen after 30 weeks, and
decreased creatinine clearance after 54 weeks. The
above results suggested that renal failure appeared
after long exposure to excessive dose of cadmium.
There have been very few reports on renal functions
of animals exposed to cadmium for a long period.
The authors feel strongly it necessary to study cad-
mium toxicity on animals after long-term exposure
to cadmium as in the present study.
In the present experiment on monkeys, hepatic
dysfunction appeared at an early stage. It should be
noticed here that the elevations ofplasma enzymes
such as GOT, GPT and LDH appeared earlier than
renal dysfunctions. Therefore, hepatic dysfunctions
seemed a sensitive index for cadmium effects.
Axelsson and Piscator (22) observed the elevation
of serum GOT after 17 weeks in rabbits injected
with 0.25 mg Cd/kg-day. At the 17th week, hepatic
cadmium concentration was 450 Ag/g. Kimura (23)
also reported increased plasma GOT and GPT in
rabbits after 2 weeks subcutaneous Cd injection of2
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FIGURE 16. Pathological changes at 300 ppm Cd (1) Histology of the renal cortex of animal #1253 showing atrophy in the proximal
portion ofnephron with abundant degenerative epithelium, x300; (2) Animal #1243 occasional swollen eosinophilic large tubule are
seen, oblique section, x300; (3) Animal #1243, dark stained degenerative cells and vivid intact epithelium detected in the same
proximal convolution, x600; (4) Animal #1253, a group of swollen eosinophilic large tubules, Cross section, x300; (5) Animal
#1243, a few mitotic figures are clearly seen in the proximal portion. x600. Animal (6) #1243 thickened basement membrane and
sweiling ofepithelial liningofBowman's capsule, x300; (7) Animal #1243, small round cell infiltration in the interstitial tissue ofthe
cortex, x300; (8) Animal #1253, glomerulus containing increased number of nuclei and enlarged moderately, x300.
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AwilTable 6. Pathological flndings.
Organ Findings
Heart Focal myocarditis
Intimal thickening of coronary arteriole
Aorta Edema of intima
Intimal thickening
Sparse and edematous change of inner media
Spleen Follicles with germinal center
Swelling ofcapillary wall in the follicle
Hemosiderosis
Lung Lung mites
Golden brown-black pigmentation
Localized bronchiolitis and peribronchiolitis
Focal pneumonia
Bronchioloectasia
Emphysema
Perivascular cell infiltration
Lymphoid foci
Adhesive pleurisy
Tongue Small round cell infiltration
Salivary Small round cell infiltration
glands Fibrosis and stasis of secretion
Tonsila Follicles with germinal center
Hemorrhage
Esophagus Small round cell infiltration
Lymphoid foci
Gongylonemiasis
Stomach Small round cell infiltration
Lymphoid foci
Eosinophilic infiltration
Adenomatous polyp (Nochtia nochti infection)
Duodenum Desquamation of epithelial cells
Fusing of villi
Necrotic changes of villi
Small round cell infiltration
Lymphoid foci
Hemosiderosis
Jejunum- Increase ofgoblet cells
ileum Small round cell infiltration
Eosinophilic infiltration
Hyperplasia of Peyer's palates
Large Trichuriasis
intestine Oesophagostomiasis
Diverticulosis of the large intestine
Small round cell infiltration
Eosinophilic infiltration
Hyperplasia of lymph nodules
Mesenteric Atrophy offollicles
nodes Follicles with germinal center
Swelling of capillary wall in the follicle
Sinus catarrh
Hemosiderosis and erythrophagia
Pancreas Large islets of Langerhans
Small round cell infiltration
300 ppm 30 ppm 3 ppm 0 ppm
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300 ppm 30 ppm 3 ppm 0 ppm
Organ Findings #1253 #1243 #1213 #1202 #1247 #1258 #1244 #1249 #1248 #1259
Liver Centrolobular swelling
Diffuse swelling
Peripheral vacuole degeneration
Activation of Kupffer cells
Small necrotic foci
Cholangiolar hyperplasia
Cell infiltration in the portal areas
Gallbladder Thickening of mucous membrane
Kidney Proximal convoluted tubules:
Swelling and disintegration of brush border
Atrophy and dilatation
Proteinous fluid in the tubules
Focal area of degeneration to necrosis
Desquamative changes
Swollen eosinophilic large tubules
Regeneration of tubular epithelium
Mitosis in the tubular linings
Renal corpuscles:
Thick basement membrane of Bowman's capsule
Swelling of the lining of Bowman's capsule
Dilatation of Bowman's space
Proteinous substance in the Bowman's space
Thick basement membrane of glomerular tufts
Increase of glomerular nuclei
Interstitial tissue and lower nephron:
Small round cell infiltration
Calcification
Proteinous fluid in the collecting tubules
Eosinophilic abscess in the cortex
Urinary Hyperplastic change of epithelium
bladder Vacuole formation in the epithelial cells
Small round cell infiltration
Edema in the proprial to submucosal area
Urinary calculi
Testis and Development stage
epididymis Spermatogenesis
Prostate Development stage
Small round cell infiltration
Pituitary Decrease of acidophile cells
Cysts in the anterior lobe
Thyroid Small round cell infiltration
Thymus Regressive change
Adrenals Cortical thickening
Increase of lipid in the cortical cells
Degenerative changes of Z. reticularis
Pigmentation or histiocytic infiltration
Brain
Bone
Bone marrow
a Collecting tubules contained desquamated epithelial cells.
b OB = no remarkable lesion.
c Hemorrhages observed around IV ventricle.
d Subependymal edema and edema of Virchow-Robin space.
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February 1979 239mg/kg-day. It is very necessary to study liver func-
tion in cadmium intoxication further. Furthermore,
although Nomiyama et al. (24) reported a marked
decrease in the albumin to globulin ratio in plasma
of rabbits given subcutaneous injections of cad-
mium, no significant changes were observed in the
present experiment.
There have been many reports on anemia in ani-
mals given cadmium. In the present experiment,
anemia appeared at an early stage in the 300 ppm
group monkeys. Anemia is, as is well known,
caused by many etiologies. Therefore, it is very dif-
ficult to say definitely whether cadmium pollution
causes anemia in the general population. However,
it might be possible to employ anemia as index for
health effects of cadmium in human beings. As to
the etiology of cadmium anemia, iron deficiency
was thought to be one ofthe etiological agents, be-
cause iron administration was effective for anemia
in cadmium poisoning (25). Another suspected
etiology was an increased destruction of erythro-
cytes (26, 27). In the present experiment a slight
shift to the left of leucocytes in the hemogram was
observed, but there was no decrease in leucocyte
counts especially in neutrophilic leucocytes.
Therefore, anemia presumably is not related to
bone marrow dysfunction. Neutrophils of the 300
ppm group monkeys, furthermore, increased during
the experiment. This fact suggested acute
hemopoietic reactions against cadmium.
No relationships were observed between cad-
mium dose and plasma calcium. The 300 ppm group
monkeys showed markedly decreased plasma
phosphate right after cadmium administration and
slightly depressed tubular reabsorption of phos-
phate after 28 weeks, but no increase in plasma al-
kaline phosphatase on a group basis. These results
suggest some cadmium effects on bone in rhesus
monkeys. There were no significant changes in
electrocardiogram and blood pressure due to cad-
mium in the present experiment. However, there
might be many abnormalities in the electrocardio-
gram at the beginning of experiment. As was al-
ready shown by Perry et al. (28), the blood pressure
was unnecessary to indicate high blood pressure
levels throughout the cadmium administration
period. Therefore, electrocardiogram and blood
pressures should be checked consecutively
throughout the experiment and compared with the
results before the experiment.
Dose-Response Relationships and Critical
Concentration of Cadmium
In the present experiment, monkeys were given
cadmium orally at dose levels of 0, 0.3, 3, and 30
mg/day per animal, that is, 100 g pelleted food con-
taining0, 3, 30, and 300 ppm cadmium as mentioned
above.
In the 3 ppm group, no other health effects were
observed than (1) one monkey gained little weight
during the experiment, (2) there was a gradual de-
crease of plasma phosphate with time of experi-
ment, and (3) renal pathological changes such as
swelling of renal tubular epithelium occurred.
In the 30 ppm group, there was one monkey
which showed reduced gain in body weight, in-
creased urine protein concentration, and pathologi-
cal swelling and uneven brush border ofrenal tubu-
lar cells. The urine cadmium was 20-60 ,ug/l., and
cadmium concentrations in renal cortex of two
monkeys were 460 and 730,g/g. These data suggest
that the critical concentration ofcadmium is below
460 ,ug/g.
In the 300 ppm group marked effects were seen.
In particular, retinol-binding proteinuria and he-
patic dysfunction were detected first on 12 weeks of
experiment; at 24 weeks urine cadmium was 200-
1000 Ag/l., and the cadmium concentration in the
renal cortex and the liver were 757 and 427 ,ug/g,
respectively. The above data suggested that the
critical concentrations ofcadmium in the renal cor-
tex and the liver were below 379 and 214 ,sg/g, re-
spectively. (Ifcadmium were accumulated in organs
at a constant rate, the cadmium concentration in
renal cortex at 12 weeks would be 757 ,ug/g x 12/24
= 379,ug/g; the cadmium concentration in liverat 12
weeks would be 427 ,mg/g x 12/24 = 214 ,ug/g). Pro-
teinuria, glycosuria, and aminoaciduria appeared at
15-16 weeks, and the critical concentration of cad-
mium in renal cortex for proteinuria, glycosuria,
and aminoaciduria was estimated as 473 ,ug/g, in
agreement with the estimated critical concentration
for the 30 ppm group below 460 ,ug/g. Furthermore
at 55 weeks, very slight pathological changes in
renal tubules were observed in the renal cortex
containing 300-465 ug/g cadmium, and significant
pathological changes were recognized in the renal
cortex containing 410-630 ,ug/g. The estimated crit-
ical concentration based on histopathology data
agreed well with the estimate based on clinical
pathology data.
The above results suggest a minimum effective
oral dose of cadmium for male rhesus monkeys of
2520 mg (equivalent to 720 mg/kg), that is, 30 mg
Cd/day per animal for 12 weeks. The critical con-
centration of cadmium in the renal cortex was 380
,ug/g for low molecular weight proteinuria, and 470
,ug/g for proteinuria, glycosuria, and aminoaciduria.
Furthermore, symptoms of cadmium intoxication
appeared when urine cadmium concentration ex-
ceeded 20,ug/l. The critical cadmium concentration
in the liver was estimated at 210 ,ug/g.
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feaedimng Peod, Cd in liver, ,ug/g wet weight Cd in renal cortex,,Ag/g wet weight
level, ppm week Animal Jichi Kobe Keio Jichi Kobe Keio
300 24 1253 406.8 390 51.7 763.0 672 121.0
446.2 750.0
55 1213 630.4 502 550.9 587.2 452 461.7
630.4 578.1
55 1243 407.8 303 345.3 365.7 298 326.3
411.8 334.6
30 24 1202 54.1 49.6 7.5 303.6 311 63.5
57.5 295.3
55 1247 158.2 131 131.6 728.4 588 540.6
164.5 726.1
55 1258 110.6 113 107.1 468.2 458 402.0
113.2 461.4
3 55 1244 41.9 26.8 37.4 163.7 99 161.5
39.7 157.7
55 1249 34.3 28.7 30.9 229.4 174 181.9
37.7 256.6
0 55 1248 35.4 26.5 35.2 181.0 124 125.9
36.9 179.3
55 1259 16.5 14.4 14.0 143.4 114 132.0
17.0 146.8
Tissue Cadmium
As already mentioned in the results section, as
dose of tissue cadmium increased, a larger portion
ofthe cadmium accumulated in the liver. This might
cause hepatic dysfunction at an early stage of cad-
mium intoxication in monkeys. Cadmium also ac-
cumulated in endocrine organs such as pancreas,
submandibular glands, and parotids. Therefore, it is
necessary to study endocrine organs in future cad-
mium intoxication studies. Simultaneous and com-
parative determinations of tissue cadmium were
performed at Jichi Medical School, Kobe Univer-
sity and Keio University at 24 weeks. Most results
agreed well with each other as shown in Table 7.
Analytical results of Jichi Medical School, where
tissue cadmium was determined with the use of 1 g
samples weighed at time of sampling were signifi-
cantly higher than those obtained at Kobe Univer-
sity, where tissue cadmiun was determined with the
use ofsamples ofsmaller pieces weighed some time
aftersampling. Both Jichi Medical School and Kobe
University determined cadmium by correcting the
background with a deuterium lamp. Therefore, it is
not clear what caused the difference in the results.
Duplicate determinations at Jichi Medical School
agreed well with each other. Based on the above
reason, tissue cadmium in the present paper is dis-
cussed on the basis of analytical data from Jichi
Medical School.
In the present experiment, no significant differ-
ences were observed in cadmium concentration in
Table 8. Cadmium level in untreated monkey tissues.
Cd level, ,ug/g
Animal Institution Liver Renal Cortex
1256 Jichi 1.75 16.01
3.89 16.27
35 Azabu 0.27 6.26
0.35 5.04
0.34 5.53
the renal cortex and the liver between the 0 ppm
group and 3 ppm group. Specifically, the liver to
renal cortex ratio ofcadmiumofmonkey #1248 was
0.20, which was almost the same as that of two
monkeys of the 3 ppm group (0.25 and 0.16). This
suggested that monkey #1248 of the 0 ppm group
was exposed to cadmium. Feces cadmium of mon-
key #1248 was sometimes extraordinarily high.
Urine cadmium concentration on monkey #1248
was also occasionally higher than that ofthe 3 ppm
group monkeys. From monkey food powder left in
the foodbox ofmonkey #1248, 3 ppmcadmium was
detected. It was impossible for a monkey to take
food from the next monkey, because each monkey
cage was situated about 5 cm away from the next
cage. It is possible, therefore, that inadvertently
cadmium was fed several times to monkey #1248 of
the 0 ppm group. Furthermore, feces cadmium con-
centrations of most monkeys were very high in the
untreated period, but feces cadmium of monkey
#1259 ofthe 0 ppm group decreased when pelleted
food was changed from Oriental Co. to CLEA. This
February 1979Table 9. Calculation of apparent biological half-time of cadmium in rhesus monkeys at sacrifice at 55 weeks.
300 ppm 30 ppm 3 ppm 0 ppm
#1213 #1243 #1247 #1258 #1244 #1249 #1248 #1259
Body weight at sacrifice, kg 4.63 4.01 4.36 6.13 5.17 4.97 4.83 5.28
Total body burden of Cd, mg 163 65.4 34.4 30.9 5.60 7.05 6.12 4.10
Avg body concn, ug/g 35.2 16.3 7.89 5.04 1.08 1.42 1.27 0.78
Intestinal absorption, % 3.0 1.8 3.9 3.6 6.5 8.2 6.9 4.7
Cd uptake/day, ,tg 771 453 100 91.5 16.7 21.2 16.6 11.3
Fecal Cd excretion/day, ,tg 350 280 9.5 10.1 2.0 2.6 0.46 0.40
Avg Cd deposit/day, ,ug 421 173 90.5 81.4 14.7 18.6 16.1 10.9
Liver and kidney Cd, mg 59.6 33.0 24.2 23.2 3.87 5.35 4.23 3.29
Ratio of total body burden 2.76 1.98 1.42 1.33 1.45 1.32 1.45 1.25
the liver and kidney Cd
Apparent biological half- 0.88 0.44 6.9 5.8 5.3 5.1 25.3 19.5
time at sacrifice, yr.
suggests unfortunately that there was some cad-
mium exposure of monkeys before the experiment.
Based on the above reasons, tissue cadmium was
determined on two further untreated monkeys. As
shown in Table 8, tissue cadmium levels were low,
with liver to renal cortex ratios of cadmium as low
as 0.17 and 0.06, respectively. These data support
the suggestion that monkey #1248 of the 0 ppm
group was given cadmium because of feeding er-
rors. In spite of this probable error, no health ef-
fects were observed in monkey #1248. This suggests
that occasional administrations of cadmium at a
high level increases cadmium accumulation in the
body, but that no health effects appearbefore tissue
cadmium reaches the critical concentration.
Apparent Biological Half-Time of Cadmium
at Sacrificed Stage
Cadmium is accumulated in the body, but little is
excreted into urine and feces. Cadmium is trans-
ported from the liver to the kidneys. Because ofthe
toxicodynamic features of cadmium, the biological
half-time ofcadmium should noi be calculated on a
one-compartment model. However, to compare the
biological half-time by dose level the apparent
biological half-time of cadmium at sacrificed stage
in Table 9 was, tentatively, calculated from the fol-
lowing equation:
k = In 2/biological half-time
= cadmium excretion (per day)/total body
burden of cadmium
The average apparent biological half-time of the 0
ppm group was 22.4 years, ofthe 3 ppm group, 5.2
years; ofthe 30 ppm group, 6.4 years; and ofthe 300
ppm group, 0.66 years. These results suggest that
the more cadmium taken into the body, the shorter
is the apparent biological half-time. Most metal
toxicology researchers believe the idea that the ap-
parent "biological half time of cadmium" is quite
long, regardless ofthe exposure level (29-31); this is
not borne out by our data presented here. However,
it should be noticed that the results here agree well
with our previous data on the apparent biological
half-time of rabbit plasma cadmium (32) and cad-
mium ofrabbit renal cortex and liver (33) as well as
cadmium of mouse kidney and liver (34). The ap-
parent biological half-time in all the above experi-
ments became shorter as animals were given more
cadmium. It seems quite natural from the viewpoint
of biology that an animal excretes more poisonous
metals from the body when excessive dose of
poisonous metals are given.
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